The development and commercialization of CAR T-cell therapy in China exhibit significant geographical clustering, primarily centered in major economic and scientific hubs. The most intensive activity is concentrated in the Yangtze River Delta (Shanghai, Jiangsu), the Greater Bay Area (Guangzhou, Shenzhen), and the Beijing-Tianjin region. These areas benefit from a high density of...